CPDA-1 209 mg/70mL

CPDA-1 209 mg/70mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine, ensuring blood viability during storage.

CPDA-1 209 mg/70mL is primarily used to prevent blood clotting in collected blood. This solution is designed to maintain the quality and viability of blood components, such as red blood cells, during storage. It is commonly used in medical settings where blood preservation is necessary, such as blood banks and hospitals. The solution helps extend the shelf life of blood products, ensuring they remain viable for transfusion.

CPDA-1 209 mg/70mL works by inhibiting the clotting process, allowing blood to be stored safely. The solution contains citrate, which binds calcium ions and prevents coagulation. Phosphate and dextrose provide nutrients to maintain red blood cell metabolism, while adenine helps preserve the energy levels of the cells. These combined effects ensure that the blood remains viable for a longer period.

CPDA-1 209 mg/70mL should be handled with care to maintain sterility. It is important to follow proper storage guidelines to ensure the solution remains effective. The solution should be stored at the appropriate temperature and protected from light. Always check the expiration date before use. Ensure that the solution is administered by trained medical professionals to avoid any complications.

CPDA-1 209 mg/70mL may interact with certain medications or substances. It is important to inform healthcare providers about any other medications being taken. The solution should not be mixed with other solutions unless specifically instructed by a medical professional. Always follow the guidelines provided by the manufacturer and healthcare providers to ensure safe and effective use.